{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00757",
      "entity_text" : "MDSC",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0087" ],
      "CellLine" : [ "cellosaurus:CVCL_E508" ],
      "Organ" : [ "uberon:UBERON:0002405" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0000763" ]
    }
  },
  "verbose_text" : "In CML, increased levels of MDSC, which originate from the malignant BCR-ABL1 clone, are also observed, and these MDSC subsequently reduce following highly efficacious TKI therapy.",
  "reading_complete" : "2020-08-04T10:01:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:57:39Z",
  "trigger" : "levels",
  "evidence" : [ "levels of MDSC" ],
  "pmc_id" : "5402174",
  "score" : 0
}